A stock qualifies when its close is within 2.5% of the 20-session high, its close is above SMA 50, and relative volume is at least 1.25× the 20-session average.
LATEST EOD RESULTS
27 qualifying stocks
| # | Company | Close | Day | Rel volume | RSI 14 | vs SMA 50 | 20D high gap | Trend context |
|---|---|---|---|---|---|---|---|---|
| 1 | BANK OF BARODABANKBARODAF&O | ₹260.01 | 0.0% | 1.66× | 83.2 | +27.8% | 0.0% | Near breakout |
| 2 | BANK OF INDIABANKINDIAF&O | ₹145.00 | 0.0% | 1.45× | 76.2 | +24.0% | 0.0% | Near breakout |
| 3 | AUROBINDO PHARMA LTDAUROPHARMAF&O | ₹1,855.30 | 0.0% | 2.01× | 64.2 | +1.8% | -0.0% | Near breakout |
| 4 | INDIAN BANKINDIANBF&O | ₹933.70 | 0.0% | 1.70× | 76.6 | +14.2% | -0.1% | Near breakout |
| 5 | Havells IndiaHAVELLS · ElectricalsF&O | ₹1,159.50 | 0.0% | 1.71× | 73.3 | +14.0% | -0.1% | Near breakout |
| 6 | ICICI BankICICIBANK · Private BankF&O | ₹1,589.00 | 0.0% | 1.52× | 81.7 | +14.8% | -0.2% | Near breakout |
| 7 | Larsen & ToubroLT · Engineering & ConstructionF&O | ₹4,185.00 | 0.0% | 1.30× | 79.1 | +9.4% | -0.2% | Near breakout |
| 8 | PUNJAB NATIONAL BANKPNBF&O | ₹132.17 | 0.0% | 1.58× | 81.6 | +30.4% | -0.2% | Near breakout |
| 9 | HDFC BankHDFCBANK · Private BankF&O | ₹798.15 | 0.0% | 1.65× | 65.5 | +3.0% | -0.5% | Near breakout |
| 10 | GAIL (INDIA) LTDGAILF&O | ₹188.00 | 0.0% | 1.26× | 73.8 | +9.1% | -0.5% | Near breakout |
| 11 | KALYAN JEWELLERS IND LTDKALYANKJILF&O | ₹611.00 | 0.0% | 2.16× | 66.2 | +1.2% | -0.6% | Near breakout |
| 12 | State Bank of IndiaSBIN · PSU BankF&O | ₹1,042.00 | 0.0% | 1.76× | 72.9 | +8.6% | -0.6% | Near breakout |
| 13 | HINDALCO INDUSTRIES LTDHINDALCOF&O | ₹960.00 | 0.0% | 1.81× | 60.2 | +0.1% | -0.8% | Near breakout |
| 14 | INDIAN RENEWABLE ENERGYIREDAF&O | ₹119.65 | 0.0% | 4.94× | 71.0 | +8.0% | -0.9% | Near breakout |
| 15 | Uno MindaUNOMINDA · Auto ComponentsF&O | ₹1,353.80 | 0.0% | 1.38× | 73.0 | +7.9% | -1.0% | Near breakout |
| 16 | LAURUS LABS LIMITEDLAURUSLABSF&O | ₹2,454.00 | 0.0% | 1.59× | 77.4 | +22.5% | -1.0% | Near breakout |
| 17 | OBEROI REALTY LIMITEDOBEROIRLTYF&O | ₹1,775.00 | 0.0% | 2.92× | 62.9 | +2.4% | -1.1% | Near breakout |
| 18 | Muthoot FinanceMUTHOOTFIN · Gold-Loan NBFCF&O | ₹2,917.60 | 0.0% | 1.40× | 72.6 | +10.2% | -1.1% | Near breakout |
| 19 | Mankind PharmaMANKIND · PharmaF&O | ₹2,668.30 | 0.0% | 1.63× | 72.1 | +14.0% | -1.4% | Near breakout |
| 20 | OIL AND NATURAL GAS CORP.ONGCF&O | ₹233.50 | 0.0% | 1.70× | 55.1 | +0.6% | -1.4% | Near breakout |
| 21 | Alkem LaboratoriesALKEM · PharmaF&O | ₹5,398.50 | 0.0% | 1.59× | 65.9 | +3.9% | -1.4% | Near breakout |
| 22 | INDIAN OIL CORP LTDIOCF&O | ₹146.85 | 0.0% | 1.71× | 71.1 | +4.8% | -1.5% | Near breakout |
| 23 | Glenmark PharmaceuticalsGLENMARK · PharmaF&O | ₹2,671.10 | 0.0% | 1.84× | 79.4 | +15.6% | -1.6% | Near breakout |
| 24 | Page IndustriesPAGEIND · ApparelF&O | ₹36,380.00 | 0.0% | 1.43× | 56.6 | +1.2% | -1.9% | Near breakout |
| 25 | Sun PharmaceuticalSUNPHARMA · PharmaF&O | ₹1,904.50 | 0.0% | 1.40× | 60.0 | +0.1% | -2.0% | Near breakout |
| 26 | Divi's LaboratoriesDIVISLAB · Pharma CDMOF&O | ₹11,565.50 | 0.0% | 2.96× | 75.9 | +12.1% | -2.2% | Near breakout |
| 27 | ASHOK LEYLAND LTDASHOKLEYF&O | ₹174.86 | 0.0% | 1.37× | 64.5 | +1.8% | -2.2% | Near breakout |
End-of-day prices from the exchanges’ published bhavcopy files (NSE and BSE). Calculations and rankings by Gale.in. Prices are not live.
What makes a breakout worth investigating
Price pressing against resistance shows demand has absorbed much of the available supply at that level. An upward-sloping trend and expanding volume make the setup more informative, because the move is not relying on price proximity alone.
The 20-session high is only a short-term boundary. Before acting, zoom out to the weekly chart. A candidate can clear a one-month high and still run directly into a much larger six-month or all-time resistance zone.
Plan for false breakouts
A breakout can trade above resistance intraday and close back inside the range. It can also succeed briefly before news or broad-market weakness reverses it. Waiting for a close, a retest or a second session of confirmation reduces some false signals but can produce a later entry.
Define invalidation before considering upside. If the distance to a logical invalidation point is too large for the intended position size, the setup is not suitable even when every screening condition is true.
Checks before using this screen
- Confirm the exchange announcement and results calendar for event-driven moves.
- Review liquidity using traded value and spread—not share volume alone.
- Zoom out to the weekly chart for larger support and resistance zones.
- Define an invalidation level and position risk before considering an entry.
- Recheck fundamentals; a technical condition does not repair a broken business thesis.
FAQ
Questions about this screen
Is a near-breakout stock already a buy?
No. It is a research candidate meeting stated price, trend and volume conditions. Resistance, liquidity, news and risk still require review.
Why use a 20-session high?
It provides a consistent short-term boundary covering roughly one trading month. Longer weekly resistance remains important.
Why require volume and SMA 50?
Volume tests participation, while price above SMA 50 adds medium-term trend context. Neither condition guarantees success.